Clinical characteristic analyses showed that elevated risk scores were significantly associated with adverse clinicopathological features, including AFP >= 400 ng/ml, age<60 years, poor pathological grade, larger tumor size and advanced TNM stage (Figure 8A-F). The gene discussed is AFP; the disease is neoplasm.